| Dr Alexandra Landers Lataille, MD | |
|
1325 Spring St, Greenwood, SC 29646-3860 | |
| (864) 725-4111 | |
| Not Available |
| Full Name | Dr Alexandra Landers Lataille |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 9 Years |
| Location | 1325 Spring St, Greenwood, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538549639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 38229 (South Carolina) | Secondary |
| 207L00000X | Anesthesiology | 38229 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Self Regional Healthcare | Greenwood, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiology Of Greenwood Pa | 7214830579 | 35 |
News Archive
New information emerges about the novel coronavirus on a daily basis, sometimes confirming, other times contradicting what we thought we knew the day before.
People who suffer from dry mouth, or xerostomia, now have a powerful new option for relieving their symptoms. Building on the success of its antioxidant oral care product line, Dallas-based PerioSciences LLC is launching Dry Mouth AO ProGel and a new MILD formula of its Hydrating AO ProRinse. The new products, along with the established Hydrating AO ProRinse and AO ProToothpaste, provide a complete Hydrating Oral Care System.
NUST MISIS scientists have developed a new type of membrane test strip for the quantitative immunochromatographic rapid-test that will be able to accurately and quickly make an early diagnosis of an acute myocardial infarction through the presence of disease markers in blood, as well as to identify various things such as sepsis, a pregnancy's duration, and viral & bacterial infections.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research and the UBS Oncology Impact Fund managed by MPM Capital.
› Verified 1 days ago
| Entity Name | Anesthesiology Of Greenwood Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932189081 PECOS PAC ID: 7214830579 Enrollment ID: O20040202000729 |
News Archive
New information emerges about the novel coronavirus on a daily basis, sometimes confirming, other times contradicting what we thought we knew the day before.
People who suffer from dry mouth, or xerostomia, now have a powerful new option for relieving their symptoms. Building on the success of its antioxidant oral care product line, Dallas-based PerioSciences LLC is launching Dry Mouth AO ProGel and a new MILD formula of its Hydrating AO ProRinse. The new products, along with the established Hydrating AO ProRinse and AO ProToothpaste, provide a complete Hydrating Oral Care System.
NUST MISIS scientists have developed a new type of membrane test strip for the quantitative immunochromatographic rapid-test that will be able to accurately and quickly make an early diagnosis of an acute myocardial infarction through the presence of disease markers in blood, as well as to identify various things such as sepsis, a pregnancy's duration, and viral & bacterial infections.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research and the UBS Oncology Impact Fund managed by MPM Capital.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Landers Lataille, MD 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425-8905 Ph: () - | Dr Alexandra Landers Lataille, MD 1325 Spring St, Greenwood, SC 29646-3860 Ph: (864) 725-4111 |
News Archive
New information emerges about the novel coronavirus on a daily basis, sometimes confirming, other times contradicting what we thought we knew the day before.
People who suffer from dry mouth, or xerostomia, now have a powerful new option for relieving their symptoms. Building on the success of its antioxidant oral care product line, Dallas-based PerioSciences LLC is launching Dry Mouth AO ProGel and a new MILD formula of its Hydrating AO ProRinse. The new products, along with the established Hydrating AO ProRinse and AO ProToothpaste, provide a complete Hydrating Oral Care System.
NUST MISIS scientists have developed a new type of membrane test strip for the quantitative immunochromatographic rapid-test that will be able to accurately and quickly make an early diagnosis of an acute myocardial infarction through the presence of disease markers in blood, as well as to identify various things such as sepsis, a pregnancy's duration, and viral & bacterial infections.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research and the UBS Oncology Impact Fund managed by MPM Capital.
› Verified 1 days ago
Dr. Kirsten Alayna Dahl, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1325 Spring St, Greenwood, SC 29646 Phone: 864-227-8242 | |
William G Devore, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1325 Spring St, Greenwood, SC 29646 Phone: 864-725-4111 | |
Dr. Derek Scott Harwell, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1325 Spring St, Anesthesia Dept, Greenwood, SC 29646 Phone: 864-227-4111 | |
Dr. Kelley T Watson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1325 Spring St, Anesthesia Dept, Greenwood, SC 29646 Phone: 864-227-4111 | |
Dr. William Fred Hubbard Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1325 Spring St, Greenwood, SC 29646 Phone: 864-725-4111 | |
Dr. William R Warner, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1325 Spring St, Anesthesia Dept, Greenwood, SC 29646 Phone: 864-227-4111 | |
Dr. Jeffrey A Dean, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1325 Spring St, Greenwood, SC 29646 Phone: 864-725-4111 |